{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T04:46:46Z","timestamp":1771303606810,"version":"3.50.1"},"reference-count":88,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.ymgme.2004.08.014","type":"journal-article","created":{"date-parts":[[2004,10,4]],"date-time":"2004-10-04T19:02:24Z","timestamp":1096916544000},"page":"93-102","source":"Crossref","is-referenced-by-count":115,"title":["Impact of genetic variation of PPAR\u03b3 in humans"],"prefix":"10.1016","volume":"83","author":[{"given":"Aline","family":"Meirhaeghe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Amouyel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2004.08.014_bib1","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"mPPAR\u03b32: tissue-specific regulator of an adipocyte enhancer","volume":"8","author":"Tontonoz","year":"1994","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymgme.2004.08.014_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0092-8674(00)81359-8","article-title":"Adipogenesis and obesity: rounding out the big picture","volume":"87","author":"Spiegelman","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2004.08.014_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-5793(98)01273-3","article-title":"PPAR\u03b33 mRNA: a distinct PPAR\u03b3 mRNA subtype transcribed from an independent promoter","volume":"438","author":"Fajas","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2004.08.014_bib4","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus, and hypertension","volume":"402","author":"Barroso","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2004.08.014_bib5","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/diabetes.52.4.910","article-title":"Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma","volume":"52","author":"Savage","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1210\/jc.87.1.408","article-title":"A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy","volume":"87","author":"Agarwal","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2004.08.014_bib7","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2337\/diabetes.51.12.3586","article-title":"PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy","volume":"51","author":"Hegele","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib8","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJM199810013391403","article-title":"Obesity associated with a mutation in a genetic regulator of adipocyte differentiation","volume":"339","author":"Ristow","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2004.08.014_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1530\/eje.0.1410090","article-title":"Missense variants in the human peroxisome proliferator-activated receptor-gamma2 gene in lean and obese subjects","volume":"141","author":"Hamann","year":"1999","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ymgme.2004.08.014_bib10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/sj.ijo.0801214","article-title":"Variation in the gene for human peroxisome proliferator activated receptor gamma (PPARgamma) does not play a major role in the development of morbid obesity","volume":"24","author":"Evans","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ymgme.2004.08.014_bib11","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s001250051243","article-title":"Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men","volume":"42","author":"Ek","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.ymgme.2004.08.014_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/CS19990324","article-title":"The Pro-115\u2192Gln mutation in peroxisome-proliferator-activated receptor (PPAR) gamma2 is extremely rare in a large cohort of US Caucasians","volume":"99","author":"Terrett","year":"2000","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ymgme.2004.08.014_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.ijo.0801191","article-title":"The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes","volume":"24","author":"Clement","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ymgme.2004.08.014_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2003-39235","article-title":"Analysis of the relationship between PPAR-gamma 2 gene variants and severe insulin resistance in obese patients with impaired glucose tolerance","volume":"111","author":"Bluher","year":"2003","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/hmg\/7.3.435","article-title":"A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans","volume":"7","author":"Meirhaeghe","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2004.08.014_bib16","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1210\/jc.2002-021816","article-title":"Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome","volume":"88","author":"Orio","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2004.08.014_bib17","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1210\/jc.84.10.3708","article-title":"Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women","volume":"84","author":"Valve","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2004.08.014_bib18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0008-6363(99)00256-4","article-title":"Peroxisome proliferator-activated receptor gamma C161\u2192T polymorphism and coronary artery disease","volume":"44","author":"Wang","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ymgme.2004.08.014_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/bbrc.1997.7798","article-title":"Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR\u03b3) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation","volume":"241","author":"Yen","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2004.08.014_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/3099","article-title":"A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity","volume":"20","author":"Deeb","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2004.08.014_bib21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/bbrc.2000.2605","article-title":"The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes","volume":"271","author":"Hara","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2004.08.014_bib22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2337\/diabetes.50.4.891","article-title":"The Pro12\u2192Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes","volume":"50","author":"Mori","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/mgme.2000.2999","article-title":"The peroxisome proliferator-activated receptor gamma 2 Pro12Ala mutation is associated with early onset extreme obesity and reduced fasting glucose","volume":"70","author":"Li","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2004.08.014_bib24","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2337\/diabetes.50.4.886","article-title":"The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences","volume":"50","author":"Douglas","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2337\/diabetes.52.1.194","article-title":"Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both?","volume":"52","author":"Poulsen","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib26","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1210\/jc.85.5.2014","article-title":"Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree","volume":"85","author":"Hegele","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2004.08.014_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-2001-14838","article-title":"Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes","volume":"109","author":"Evans","year":"2001","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib28","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.2337\/diabetes.51.8.2581","article-title":"Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study","volume":"51","author":"Lindi","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib29","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.2337\/diabetes.48.7.1466","article-title":"Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes","volume":"48","author":"Mancini","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1006\/bbrc.1998.9962","article-title":"Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus","volume":"254","author":"Ringel","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2004.08.014_bib31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-2002-23487","article-title":"Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPAR\u03b32) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients","volume":"110","author":"Zietz","year":"2002","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0168-8227(03)00164-5","article-title":"The Pro12Ala polymorphism of PPARgamma2 gene and susceptibility to type 2 diabetes mellitus in a Polish population","volume":"62","author":"Malecki","year":"2003","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ymgme.2004.08.014_bib33","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1210\/jc.85.5.1801","article-title":"Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects","volume":"85","author":"Oh","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2004.08.014_bib34","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.2337\/diabetes.52.7.1864","article-title":"A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians","volume":"52","author":"Muller","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/79839","article-title":"The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes","volume":"26","author":"Altshuler","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2004.08.014_bib36","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00125-003-1323-1","article-title":"Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes","volume":"47","author":"Doney","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.ymgme.2004.08.014_bib37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2337\/diabetes.49.5.677","article-title":"Fuel selection in human skeletal muscle in insulin resistance: a reexamination","volume":"49","author":"Kelley","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib38","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s001090100255","article-title":"Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance","volume":"79","author":"Chuang","year":"2001","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ymgme.2004.08.014_bib39","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2337\/diabetes.52.5.1265","article-title":"The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study","volume":"52","author":"Li","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib40","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1210\/jc.87.2.772","article-title":"Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene","volume":"87","author":"Hara","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2004.08.014_bib41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/eje.0.1470495","article-title":"Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population","volume":"147","author":"Gonzalez Sanchez","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ymgme.2004.08.014_bib42","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.87.8.3989","article-title":"Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome","volume":"87","author":"Frederiksen","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2004.08.014_bib43","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1161\/01.ATV.19.12.2940","article-title":"Peroxisome proliferator-activated receptor gamma gene locus is related to body mass index and lipid values in healthy nonobese subjects","volume":"19","author":"Knoblauch","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2004.08.014_bib44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.ijo.0801112","article-title":"Impact of the peroxisome proliferator activated receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus","volume":"24","author":"Meirhaeghe","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ymgme.2004.08.014_bib45","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.2337\/diabetes.47.11.1806","article-title":"Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations","volume":"47","author":"Beamer","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib46","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.ijo.0801210","article-title":"The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans","volume":"24","author":"Cole","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ymgme.2004.08.014_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2156-3-21","article-title":"Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight","volume":"3","author":"Doney","year":"2002","journal-title":"BMC Genet."},{"key":"10.1016\/j.ymgme.2004.08.014_bib48","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0021-9150(99)00433-5","article-title":"The Pro12A1a substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia","volume":"151","author":"Pihlajamaki","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2004.08.014_bib49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/bbrc.1998.9421","article-title":"Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men","volume":"251","author":"Mori","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2004.08.014_bib50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/eje.0.1440277","article-title":"A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity","volume":"144","author":"Swarbrick","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ymgme.2004.08.014_bib51","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/jmg.40.10.773","article-title":"Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis","volume":"40","author":"Masud","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2004.08.014_bib52","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/humrep\/deg128","article-title":"Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome","volume":"18","author":"Korhonen","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ymgme.2004.08.014_bib53","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2337\/diabetes.51.8.2653","article-title":"Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study","volume":"51","author":"Herrmann","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib54","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.2337\/diabetes.52.12.3010","article-title":"The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes","volume":"52","author":"Caramori","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib55","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bjp.0703149","article-title":"Peroxisome proliferator-activated receptors in the cardiovascular system","volume":"129","author":"Bishop-Bailey","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymgme.2004.08.014_bib56","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/01.ATV.0000068680.19521.34","article-title":"Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction","volume":"23","author":"Ridker","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2004.08.014_bib57","first-page":"1007","article-title":"Diabetes mellitus and colorectal cancer risk","volume":"6","author":"La Vecchia","year":"1997","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ymgme.2004.08.014_bib58","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1074\/jbc.273.4.1855","article-title":"Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma","volume":"273","author":"Reginato","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2004.08.014_bib59","first-page":"485","article-title":"Frequent polymorphism of peroxisome proliferator activated receptor gamma gene in colorectal cancer containing wild-type K-ras gene","volume":"9","author":"Tomita","year":"2002","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ymgme.2004.08.014_bib60","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1097-2765(00)80047-7","article-title":"Terminal differentiation of human breast cancer through PPAR gamma","volume":"1","author":"Mueller","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymgme.2004.08.014_bib61","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1038\/sj.onc.1206824","article-title":"Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor gamma in the MCF-7 breast cancer cell line","volume":"22","author":"Pignatelli","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ymgme.2004.08.014_bib62","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00008571-200211000-00003","article-title":"Lack of association of the codon 12 polymorphism of the peroxisome proliferator-activated receptor gamma gene with breast cancer and body mass","volume":"12","author":"Memisoglu","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.ymgme.2004.08.014_bib63","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/pros.10058","article-title":"Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer","volume":"51","author":"Segawa","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.ymgme.2004.08.014_bib64","first-page":"3344","article-title":"Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo","volume":"58","author":"Kubota","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymgme.2004.08.014_bib65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0304-3835(02)00617-1","article-title":"Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene and risk of prostate cancer among men in a large cancer prevention study","volume":"191","author":"Paltoo","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymgme.2004.08.014_bib66","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/diabetes.51.3.867","article-title":"The proline 12 alanine substitution in the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower lipoprotein lipase activity in vivo","volume":"51","author":"Schneider","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib67","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/bbrc.2000.2096","article-title":"Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis","volume":"268","author":"Masugi","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2004.08.014_bib68","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s001250051225","article-title":"The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects","volume":"42","author":"Koch","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.ymgme.2004.08.014_bib69","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2007-978663","article-title":"The PPARgamma2 polymorphism pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients","volume":"32","author":"Jacob","year":"2000","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ymgme.2004.08.014_bib70","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2337\/diabetes.50.4.876","article-title":"Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity","volume":"50","author":"Stumvoll","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib71","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1365-2265.2002.01618.x","article-title":"Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals","volume":"57","author":"Vaccaro","year":"2002","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ymgme.2004.08.014_bib72","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-2002-23196","article-title":"Evidence for greater oxidative substrate flexibility in male carriers of the Pro 12 Ala polymorphism in PPARgamma2","volume":"34","author":"Thamer","year":"2002","journal-title":"Horm. Metab. Res"},{"key":"10.1016\/j.ymgme.2004.08.014_bib73","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000064490","article-title":"Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma is associated with increased leptin levels in women with type-2 diabetes mellitus","volume":"58","author":"Simon","year":"2002","journal-title":"Horm. Res."},{"key":"10.1016\/j.ymgme.2004.08.014_bib74","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1053\/meta.2002.35586","article-title":"PPAR(gamma)2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population","volume":"51","author":"Yamamoto","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.ymgme.2004.08.014_bib75","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1210\/jc.2002-020603","article-title":"Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects","volume":"88","author":"Kolehmainen","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2004.08.014_bib76","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s001250051660","article-title":"The expression of the p85alpha subunit of phosphatidylinositol 3-kinase is induced by activation of the peroxisome proliferator-activated receptor gamma in human adipocytes","volume":"44","author":"Rieusset","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.ymgme.2004.08.014_bib77","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00125-003-1136-2","article-title":"Genetic epistasis of adiponectin and PPARgamma2 genotypes in modulation of insulin sensitivity: a family-based association study","volume":"46","author":"Yang","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.ymgme.2004.08.014_bib78","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2337\/diacare.24.4.672","article-title":"Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferator-activated receptor-gamma2 genes and obesity","volume":"24","author":"Hsueh","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ymgme.2004.08.014_bib79","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.2337\/diabetes.49.12.2108","article-title":"Thiazolidinediones inhibit the expression of beta3-adrenergic receptors at a transcriptional level","volume":"49","author":"Bakopanos","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib80","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1034\/j.1399-0004.2003.00026.x","article-title":"The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study","volume":"63","author":"Robitaille","year":"2003","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2004.08.014_bib81","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1093\/hmg\/ddg318","article-title":"Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass","volume":"12","author":"Memisoglu","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2004.08.014_bib82","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/diabetes.50.3.686","article-title":"Evidence for gene\u2013nutrient interaction at the PPARgamma locus","volume":"50","author":"Luan","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.metabol.2003.08.005","article-title":"Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?","volume":"53","author":"Franks","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.ymgme.2004.08.014_bib84","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(89)90710-1","article-title":"Weight in infancy and death from ischaemic heart disease","volume":"2","author":"Barker","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2004.08.014_bib85","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bmj.303.6809.1019","article-title":"Fetal and infant growth and impaired glucose tolerance at age 64","volume":"303","author":"Hales","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.ymgme.2004.08.014_bib86","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2337\/diabetes.51.7.2321","article-title":"The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth","volume":"51","author":"Eriksson","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2004.08.014_bib87","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/01.ATV.0000051382.28752.FE","article-title":"A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population","volume":"23","author":"Meirhaeghe","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1016\/j.ymgme.2004.08.014_bib88","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1097-2765(00)80210-5","article-title":"PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance","volume":"4","author":"Kubota","year":"1999","journal-title":"Mol. Cell"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719204002239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719204002239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T07:51:34Z","timestamp":1549180294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719204002239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":88,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S1096719204002239"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2004.08.014","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}